U.S. COMPANY FILING
PFIZER INC — Form 8-K filed 2026-06-18
Filing text preview
Pfizer filed an 8-K on June 18, 2026, reaffirming its FY2026 guidance after announcing a CFO transition. The company maintains revenue guidance of $59.5-$62.5 billion and adjusted diluted EPS of $2.80-$3.00, originally provided on December 16, 2025 and reaffirmed on the Q1 earnings call on May 5, 2026. The filing also includes extensive risk factors.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record